Business Context and Reporting Period
This Form 6-K filing by ReWalk Robotics Ltd. (noted as Lifeward Ltd. in metadata) covers the month of April 2015. The report discloses a corporate governance event: the resignation of Dr. Hadar Ron from the Board of Directors, effective April 30, 2015.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure regarding a director's resignation and does not contain financial statements.
Material Changes
- Board Composition: Dr. Hadar Ron, appointed by shareholder Israel Healthcare Ventures in 2011, resigned from the Board.
- Independence Status: Following the resignation, four of the eight directors are independent under Nasdaq rules.
- Reason for Resignation: The filing explicitly states the resignation was not the result of any disagreement with the Company.
Guidance, Outlook, and Risks
Compliance Timeline: The Company plans to achieve a majority independent Board by no later than September 12, 2015, which is one year following its initial listing on Nasdaq, in accordance with Nasdaq corporate governance rules.
Risks: No specific financial risks or contingencies are detailed in this filing beyond the temporary non-compliance with the majority independent director requirement until the new appointment is made.
Investor Verification Checklist
- Verify the appointment of a new independent director to ensure compliance with Nasdaq rules by September 12, 2015.
- Confirm that the resignation of Dr. Ron has no undisclosed implications for the relationship with shareholder Israel Healthcare Ventures.
- Review subsequent filings for the updated Board composition and any related financial impacts.